Ha, I haven't even posted anything yet in this thread! Here goes:
Despite past skepticism, it has been established that, although it is not common, a vulnerable subpopulation of marijuana users can develop dependence. Adolescents, particularly those with conduct disorders, individuals with psychiatric disorders, or problems with substance abuse appear to be at greater risk for marijuana dependence than the general population.
CONCLUSION: A distinctive marijuana withdrawal syndrome has been identified, but it is mild and short-lived. The syndrome includes restlessness, irritability, mild agitation, insomnia, sleep EEG disturbance, nausea, and cramping.
Under "Summary and Conclusions"
http://www.rism.org/isg/dlp/ganja/analyses/Marijuana and Medicine 3a.html#psycho
And a list of some articles:
Didcott P, Reilly D, Swift W, Hall W. Long-term cannabis users on the New South Wales North Coast. NDARC Monograph No. 30. Sydney, Australia:NDARC, 1997:36-41.
http://www.ncbi.nlm.nih.gov/entrez/...ve&db=pubmed&list_uids=10812291&dopt=Citation
Swift W, Hall W, Copeland J. Cannabis dependence among long-term users in Sydney, Australia. NDARC Tech Rep No. 47. Sydney, Australia:NDARC, 1997.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=9744119&dopt=Citation
Crowley TJ, Macdonald MJ, Whitmore EA, Mikulich SK. Cannabis dependence, withdrawal, and reinforcing effects among adolescents with conduct symptoms and substance use disorders. Drug Alcohol Depend 1998;50:27-37.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=9589270&dopt=Citation
Wiesbeck GA, Schuckit MA, Kalmijn JA, Tipp JE, Bucholz KK, Smith TL. An evaluation of the history of a marijuana withdrawal syndrome in a large population. Addiction 1996;91:1469-1478
http://www.ingentaconnect.com/searc...//carfax/cadd/1996/00000091/00000010/art00006
Haney M, Ward AS, Comer SD, Foltin RW, Fischman MW. Abstinence symptoms following oral THC administration to humans. Psychopharmacology 1999;141:385-394.
http://www.springerlink.com/app/hom...,134,189;linkingpublicationresults,1:100390,1
Haney M, Ward AS, Comer SD, Foltin RW, Fischman MW. Abstinence symptoms following smoked marijuana in humans. Psychopharmacology 1999;141:395-404.
http://www.springerlink.com/app/hom...,134,189;linkingpublicationresults,1:100390,1
Aceto MD, Scates SM, Lowe JA, Martin BR. Cannabinoid precipitated withdrawal by the selective cannabinoid receptor antagonist, SR 141716A. Eur J Pharmacol 1995;282:R1-R2
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=7498260&dopt=Citation
Abood ME, Sauss C, Fan F, Tilton CL, Martin BR.Development of behavioral tolerance to delta 9-THC without alteration of cannabinoid receptor binding or mRNA levels in whole brain. Department of Pharmacology and Toxicology, Medical College of Virginia, Virginia Commonwealth University, Richmond 23298.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=retrieve&db=pubmed&list_uids=8278434&dopt=Abstract
MD Aceto, SM Scates, JA Lowe and BR Martin Dependence on delta 9-tetrahydrocannabinol: studies on precipitated and abrupt withdrawal Department of Pharmacology and Toxicology, Medical College of Virginia, Virginia Commonwealth University, Richmond, USA.
http://jpet.aspetjournals.org/cgi/c...31e4e607314ee067f9a455b5&keytype2=tf_ipsecsha
Aceto MD, Scates SM, Lowe JA, Martin BR.Cannabinoid precipitated withdrawal by the selective cannabinoid receptor antagonist, SR 141716A. Department of Pharmacology and Toxicology, Virginia Commonwealth University, Richmond 23298-0613, USA
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=retrieve&db=pubmed&list_uids=7498260&dopt=Abstract